IBM's shares fell approximately 5% in premarket trading due to disappointing quarterly revenue results that missed Wall Street estimates, despite beating profit expectations. Revenue for the third quarter was reported at $14.97 billion, below the expected $15.07 billion, due largely to reduced enterprise spending on non-GenAI projects, particularly impacting the consulting segment. IBM posted an adjusted earnings per share of $2.30, surpassing analyst expectations, driven by strong growth in its software segment, which saw a 9.7% increase in revenue. The company's AI business shows promise, with a $3 billion contribution, but challenges persist in consulting and infrastructure segments. Despite these mixed results, IBM maintains a positive outlook for revenue growth and raised its free cash flow guidance to over $12 billion for the year. Analysts remain cautious, noting that the sustainability of IBM's stock price will depend on future earnings and commentary from management.